Kaijun Geng

Title: Innovations by Kaijun Geng: A Pioneer in Benzopyrimidine and Pyrrolopyrimidine Compounds

Introduction: Kaijun Geng is a notable inventor based in Shanghai, China, who has significantly contributed to the field of pharmaceutical chemistry. With two patents to his name, his work focuses on developing innovative compounds that have promising applications in medicine.

Latest Patents: Geng's recent patents include the following groundbreaking inventions:

1. **Benzopyrimidine Compounds and Use Thereof**: This patent discloses a series of benzopyrimidine compounds, notably those represented by a specific formula, along with their pharmaceutically acceptable salts. These compounds exhibit potential therapeutic uses.

2. **Pyrrolopyrimidine Compound as BTK Inhibitor and Use Thereof**: This invention reveals a pyrrolopyrimidine compound that acts as a BTK (Bruton's tyrosine kinase) inhibitor. The patent outlines the use of this compound in preparing medications for diseases associated with BTK protein kinase inhibition.

Career Highlights: Kaijun Geng currently works at Zhejiang Longcharm Bio-tech Pharma Co., Ltd., where he is an integral part of the research team. His focus on innovative compounds aligns with the company’s mission to develop cutting-edge pharmaceutical solutions.

Collaborations: Within his professional environment, Geng collaborates with talented colleagues, including Shuhui Chen and Wentao Wu. Together, they contribute to advancing biotechnological innovations and enhancing the development of effective therapeutic agents.

Conclusion: Kaijun Geng stands as a key figure in the realm of pharmaceutical inventions. His patents on benzopyrimidine and pyrrolopyrimidine compounds reflect significant progress in drug development, marking him as a prominent inventor in the biotechnology space. His ongoing work at Zhejiang Longcharm Bio-tech serves as a testament to his commitment to innovation in the health sciences.